Johnson & Johnson (NYSE: JNJ) has gone big early doors this year in the world of pharma M&A. The US healthcare giant ...

Regeneron Pharmaceuticals today announced financial results for the fourth quarter and full year 2024 and provided a business ...

US pharma giant Pfizer reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial ...

AdvanCell announced the successful completion of an oversubscribed $112 million (US) Series C financing, making it the only ...

German biotech Akribion Therapeutics has emerged from stealth with 8 million euros ($9 million) in seed funding to accelerate ...

Sionna Therapeutics hopes to raise $150 million and secure a market capitalization of about $692 million in an initial public ...

Eleva, a German biopharmaceutical company, and 3PBIOVIAN, a global contract development and manufacturing organization (CDMO) ...

French drugmaker Mitem Pharma, which is dedicated to drugs of major therapeutic interest (DMTI), today revealed that has ...

US Senate lawmakers on Tuesday morning voted to advance Robert F Kennedy Jr's nomination to lead the US Department of Health and Human Services (HHS).

Russia is experiencing a sharp growth in the demand for drugs against diabetes this year, particular those that are also used ...

US President Donald Trump has implemented a series of tariffs on imports from Canada, Mexico and China, but the additional ...

US pharma giant Merck & Co opened Tuesday’s trading 10% lower after announcing its annual and fourth quarter financial results, along with its guidance for 2025.